Latest Articles
Personalized approaches in women’s cancer care | OPINION - Amarillo Globe-News
Personalized approaches in women’s cancer care | OPINION Amarillo Globe-News
Published: June 6, 2026, 9:45 a.m.
Why is AZ withdrawing a successful cancer drug just to give it away? - Medical Republic
Why is AZ withdrawing a successful cancer drug just to give it away? Medical Republic
Published: June 5, 2026, 5:55 a.m.
New targeted drug brings hope for women with hard-to-treat ovarian cancer - The Eastleigh Voice
New targeted drug brings hope for women with hard-to-treat ovarian cancer The Eastleigh Voice
Published: June 5, 2026, 4:16 a.m.
AstraZeneca has removed a drug for endometriosis and breast cancer from Australia - RUSSH
AstraZeneca has removed a drug for endometriosis and breast cancer from Australia RUSSH
Published: June 5, 2026, 3:45 a.m.
A lifesaving endometriosis and breast cancer drug is being pulled from the PBS – but men can still access it - bodyandsoul.com.au
A lifesaving endometriosis and breast cancer drug is being pulled from the PBS – but men can still access it bodyandsoul.com.au
Published: June 5, 2026, 3:37 a.m.
Ramez N. Eskander, MD, on Endometrial Cancer: Pembrolizumab Plus Carboplatin/Paclitaxel - The ASCO Post
Ramez N. Eskander, MD, on Endometrial Cancer: Pembrolizumab Plus Carboplatin/Paclitaxel The ASCO Post
Published: June 5, 2026, 2:51 a.m.
The frustrating reason behind key breast cancer and endometriosis drug being pulled from Australia - Women's Agenda
The frustrating reason behind key breast cancer and endometriosis drug being pulled from Australia Women's Agenda
Published: June 5, 2026, 1:35 a.m.
AUDIO: Breast cancer patients react to planned drug withdrawal - Australian Broadcasting Corporation
AUDIO: Breast cancer patients react to planned drug withdrawal Australian Broadcasting Corporation
Published: June 5, 2026, 1:32 a.m.
A drug for endometriosis and breast cancer leaves the PBS - but remains for prostate cancer - RUSSH
A drug for endometriosis and breast cancer leaves the PBS - but remains for prostate cancer RUSSH
Published: June 4, 2026, 11:21 p.m.
Noelle Cloven, MD, on RAINFOL-03: Actively Recruiting Trial in Pretreated Endometrial Cancer - The ASCO Post
Noelle Cloven, MD, on RAINFOL-03: Actively Recruiting Trial in Pretreated Endometrial Cancer The ASCO Post
Published: June 4, 2026, 10:12 p.m.
Link copied to clipboard!